Penumbra (PEN) Capital Expenditures (2014 - 2026)
Penumbra's (PEN) quarterly Capital Expenditures came in at $11.8 million in Q1 2026, up 582.05% year-on-year from $1.7 million in Q1 2025, and up 214.61% on a QoQ basis from $3.7 million in Q4 2025.
Penumbra (PEN) Capital Expenditures (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Capital Expenditures data on file, last reported at $11.8 million in Q1 2026.
- On a quarterly basis, Capital Expenditures rose 582.05% year-over-year to $11.8 million in Q1 2026; TTM through Mar 2026 was $15.3 million, a 10.2% decrease from a year earlier, with the FY2025 full-year figure at $5.3 million, down 75.03% from the prior year.
- Capital Expenditures for Q1 2026 stood at $11.8 million, up from $3.7 million in the prior quarter.
- Over the last five years, Capital Expenditures for PEN reached as high as $27.3 million in Q2 2025 and fell as low as -$27.5 million in Q3 2025.
- Historically, Capital Expenditures has averaged $2.5 million across 5 years, with a median of $4.4 million in 2022.
- Across the five-year window, Capital Expenditures surged 5875.27% in 2024 and tumbled 604.49% in 2025, its largest moves.
- Year by year, Capital Expenditures stood at -$13.4 million in 2022, then jumped by 99.31% to -$93000.0 in 2023, then jumped by 5875.27% to $5.4 million in 2024, then sank by 30.29% to $3.7 million in 2025, then surged by 214.61% to $11.8 million in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $11.8 million in Q1 2026, $3.7 million in Q4 2025, and -$27.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn | 11.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.78 Mn |
| Mar 31, 2026 | 11.78 Mn |
| Dec 31, 2025 | 3.74 Mn |
| Dec 31, 2025 | 3.74 Mn |
| Sep 30, 2025 | -27.50 Mn |
| Sep 30, 2025 | -27.50 Mn |
| Jun 30, 2025 | 27.32 Mn |
| Jun 30, 2025 | 27.32 Mn |
| Mar 31, 2025 | 1.73 Mn |
| Mar 31, 2025 | 1.73 Mn |
| Dec 31, 2024 | 5.37 Mn |
| Dec 31, 2024 | 5.37 Mn |
| Sep 30, 2024 | 5.45 Mn |
| Sep 30, 2024 | 5.45 Mn |
| Jun 30, 2024 | 4.54 Mn |
| Jun 30, 2024 | 4.54 Mn |
| Mar 31, 2024 | 5.82 Mn |
| Mar 31, 2024 | 5.82 Mn |
| Dec 31, 2023 | -93,000.00 |
| Dec 31, 2023 | -93,000.00 |